(Q39595402)

13 September 2017

1 reference

title

Clinical applications of LHRH analogues (English)

1 reference

13 September 2017

Fraser HM

1

1 reference

13 September 2017

Baird DT

series ordinal

2

1 reference

13 September 2017

publication date

1 February 1987

1 reference

Bailliere's clinical endocrinology and metabolism

13 September 2017

published in

1 reference

13 September 2017

volume

1

1 reference

13 September 2017

issue

1

1 reference

13 September 2017

page(s)

43-70

1 reference

Oestrogen replacement therapy for prevention of osteoporosis after oophorectomy

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

Reversible induction of azoospermia in rhesus monkeys by constant infusion of a gonadotropin-releasing hormone agonist using osmotic minipumps

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

The effects of an LH-RH antagonist ([N-Ac-D-Trp(1)(3), D-p-Cl-Phe(2), D-Phe(6), D-Ala(10)]-LH-RH) during the preovulatory period of the rhesus monkey

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

Suppression of postovulatory gonadotropin levels does not affect corpus luteum function in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

The effects of chronic administration of LH-RH agonists and antagonists on the menstrual cycle and endometrium of the rhesus monkey

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

Hypophysial Responses to Continuous and Intermittent Delivery of Hypothalamic Gonadotropin-Releasing Hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

Ultrasonic measurement of ovarian follicles during chronic LRH agonist treatment for contraception

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

Endometrial patterns in women on chronic luteinizing hormone-releasing hormone agonist treatment for contraception

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

Long-term intranasal luteinizing hormone-releasing hormone agonist treatment for contraception in women

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

Failure of positive feedback of oestradiol during chronic intranasal luteinizing hormone-releasing hormone agonist treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

Mechanisms of gonadotropin-releasing hormone agonist action in the human male

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

Use of a potent, long acting agonist of gonadotropin-releasing hormone in the treatment of precocious puberty

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

Administration of luteinizing hormone-releasing hormone analogs delays ovulation without affecting the luteal function in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

Specific binding of gonadotrophin-releasing hormone and an agonist to human corpus luteum homogenates: characterization, properties, and luteal phase levels.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

Menopausal flushes: effect of pituitary gonadotropin desensitization by a potent luteinizing hormone- releasing factor agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

Chorionic gonadotropin prevents LRF-agonist-induced luteolysis in the human

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

Studies on the effect of gonadotropin-releasing hormone and its agonist on human luteal steroidogenesis in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

Steroid secretion in polycystic ovarian disease after ovarian suppression by a long-acting gonadotropin-releasing hormone agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

Gonadotropin-Releasing Hormone Modulation of Its Own Pituitary Receptors: Evidence for Biphasic Regulation*

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

Cyclical ovarian function resistant to treatment with an analogue of luteinizing hormone releasing hormone in McCune-Albright syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

Induction of hot flashes in premenopausal women treated with a long-acting GnRH agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

Combined treatment with an LHRH agonist and testosterone in man. Reversible oligozoospermia without impotence

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

The Epidemiology of Cancers of the Breast and Reproductive System

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

Induction of multiple follicular growth in normally menstruating women with endogenous gonadotropin suppression

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

A new systematic treatment for infertile women with abnormal hormone profiles

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

Successful treatment of infertile women with oligomenorrhoea using a combination of an LHRH agonist and exogenous gonadotrophins

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

A conservative approach to the management of uterine leiomyoma: pituitary desensitization by a luteinizing hormone-releasing hormone analogue

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

Effect of oestrogen on gonadotrophin release in stumptailed monkeys (Macaca arctoides) treated chronically with an agonist analogue of luteinizing hormone releasing hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

Suppression of follicular maturation by infusion of a luteinizing hormone-releasing hormone agonist starting during the late luteal phase in the stumptailed macaque monkey

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

Decreased pituitary responsiveness and inhibition of the luteinizing hormone surge and ovulation in the stumptailed monkey (Macaca arctoides) by chronic treatment with an agonist of luteinizing hormone-releasing hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

Antibody production against an agonist analogue of luteinizing hormone-releasing hormone: evaluation of immunochemical and physiological consequences

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

Suppression of luteal progesterone secretion in the stumptailed macaque by an antagonist analogue of luteinizing hormone releasing hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

Effects of an LH-releasing hormone antagonist on the secretion of LH, FSH, prolactin and ovarian steroids at different stages of the luteal phase in the stumptailed macaque (Macaca arctoides)

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

Intranasal peptide contraception by inhibition of ovulation with the gonadotropin-releasing hormone superagonist nafarelin: six months' clinical results

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

Sustained gonadal suppression in fertile women with the LHRH agonist buserelin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

Toward removing uterine fibroids without surgery: subcutaneous infusion of a luteinizing hormone-releasing hormone agonist commencing in the luteal phase

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

Extrapituitary Actions of Gonadotropin-Releasing Hormone*

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

On some Late Effects of Bilateral Oophorectomy in the Age Range 15–30 Years

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

Gonadotropin-releasing hormone analog design. Structure-function studies toward the development of agonists and antagonists: rationale and perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

Ovulation inhibition by administration of weekly gonadotropin-releasing hormone antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

Induction of ovulation in primate models

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

Decreased bone density in hyperprolactinemic women

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

Anti-tumor and endocrine effects of chronic LHRH agonist treatment (Buserelin) with or without tamoxifen in premenopausal metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

Combined treatment with buserelin and cyproterone acetate in metastatic prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

Effect of Flutamide or Cyproterone Acetate on Pituitary and Testicular Hormones in Normal Men

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

Vertebral body bone mineral content in hyperprolactinemic women

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

Contraception with an LHRH agonist: effect on gonadotrophin and steroid secretion patterns

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

Elevated 1,25-dihydroxyvitamin D plasma levels in normal human pregnancy and lactation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

Treatment of prostate cancer with gonadotropin-releasing hormone agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

Sensitivity of pituitary and corpus luteum responses to single intranasal administration of (D-ser[TBU]6-des-gly-NH2(10)) luteinizing hormone-releasing hormone ethylamide (Buserelin) in normal women

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

Gonadotropins and estradiol responses to single intranasal or subcutaneous administration of a luteinizing hormone-releasing hormone agonist in the early follicular phase

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

Reversible hypogonadism induced by a luteinizing hormone-releasing hormone (LH-RH) agonist (Buserelin) as a new therapeutic approach for endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

Inhibition of ovulation during discontinuous intranasal luteinizing hormone-releasing hormone agonist dosing in combination with gestagen-induced bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

Reversible inhibition of testicular steroidogenesis and spermatogenesis by a potent gonadotropin-releasing hormone agonist in normal men: an approach toward the development of a male contraceptive

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

Intranasal and subcutaneous treatment of central precocious puberty in both sexes with a long-acting analog of luteinizing hormone-releasing hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

Luteinizing hormone-releasing hormone agonist and uterine leiomyoma: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

Treatment of breast cancer with gonadotropin-releasing hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

"Medical oophorectomy" using a long-acting GNRH agonist--a possible new approach to the treatment of endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

Stimulation of LH fragments with reduced bioactivity following GnRH agonist administration in women

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

Failure of high-dose sustained release luteinizing hormone releasing hormone agonist (buserelin) plus oral testosterone to suppress male fertility.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

Growth of human breast cancer cells inhibited by a luteinizing hormone-releasing hormone agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

The premenstrual syndrome. Effects of "medical ovariectomy"

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

Effect of bilateral ovariectomy on coronary-artery disease and serum-lipid levels

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

Induction of ovulation for in-vitro fertilisation using buserelin and gonadotropins

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

Long term treatment of male and female precocious puberty by periodic administration of a long-acting preparation of D-Trp6-luteinizing hormone-releasing hormone microcapsules

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

Early menopause and the risk of myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

Long term effects of administration of a gonadotropin-releasing hormone superagonist analog in men with prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

Ac-D-NAL(2)1,4FD-Phe2,D-Trp3,D-Arg6-LHRH, a potent antagonist of LHRH, produces transient edema and behavioral changes in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

Influence of the LH-RH analogue buserelin on cyclic ovarian function and on endometrium. A new approach to fertility control?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

Suppression of pituitary and testicular function in normal men by constant gonadotropin-releasing hormone agonist infusion.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

Use of a superactive luteinizing hormone releasing hormone (LHRH) agonist in the treatment of menorrhagia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

Effect of an intranasal LHRH agonist on gonadotrophins and hot flushes in post-menopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

The treatment of central precocious puberty using an intranasal LHRH analogue (buserelin).

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

Inhibition of human granulosa cell progesterone secretion by a gonadotropin-releasing hormone agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

Comparison of the potential for therapeutic utilities with gonadotropin-releasing hormone agonists and antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

Treatment of patients with advanced cancer of the prostate using a slow-release (depot) formulation of the LHRH agonist ICI 118630 (Zoladex)

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

Preliminary endocrinological evaluation of a sustained-release formulation of the LH-releasing hormone agonist D-Ser(But)6Azgly10LHRH in premenopausal women with advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

Reversible inhibition of testicular function by a gonadotropin hormone-releasing hormone antagonist in monkeys (Macaca fascicularis)

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

Suppression of ovarian activity by Zoladex depot (ICI 118630), a long-acting luteinizing hormone releasing hormone agonist analogue

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

Anovulatory effect of a LHRH antagonist in women

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980052-6

7 January 2021

10.1016/S0950-351X(87)80052-6

Identifiers

DOI

1 reference

release_nnjg2ty3ybdhdodklmg5n53seu

13 September 2017

Fatcat ID

0 references

1 reference